J. Jeffrey Goater
2019
In 2019, J. Jeffrey Goater earned a total compensation of $1.6M as Chief Executive Officer, President and Director at Surface Oncology, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $255,000 |
|---|---|
| Option Awards | $866,790 |
| Salary | $510,000 |
| Other | $10,473 |
| Total | $1,642,263 |
Goater received $866.8K in option awards, accounting for 53% of the total pay in 2019.
Goater also received $255K in non-equity incentive plan, $510K in salary and $10.5K in other compensation.
Rankings
In 2019, J. Jeffrey Goater's compensation ranked 6,869th out of 13,971 executives tracked by ExecPay. In other words, Goater earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,869 out of 13,971 | 51st |
Division Manufacturing | 2,623 out of 5,701 | 54th |
Major group Chemicals And Allied Products | 957 out of 2,200 | 57th |
Industry group Drugs | 808 out of 1,886 | 57th |
Industry Biological Products, Except Diagnostic Substances | 194 out of 389 | 50th |
Source: SEC filing on April 22, 2020.
Goater's colleagues
We found two more compensation records of executives who worked with J. Jeffrey Goater at Surface Oncology in 2019.